| IgG4‐related disease: clinical and laboratory features in one hundred twenty‐five patients ZS Wallace, V Deshpande, H Mattoo, VS Mahajan, M Kulikova, S Pillai, ... Arthritis & rheumatology 67 (9), 2466-2475, 2015 | 611 | 2015 |
| Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations ZS Wallace, H Mattoo, M Carruthers, VS Mahajan, E Della Torre, H Lee, ... Annals of the rheumatic diseases 74 (1), 190-195, 2015 | 507 | 2015 |
| IgG4-related disease VS Mahajan, H Mattoo, V Deshpande, SS Pillai, JH Stone Annual Review of Pathology: Mechanisms of Disease 9, 315-347, 2014 | 420 | 2014 |
| De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease H Mattoo, VS Mahajan, E Della-Torre, Y Sekigami, M Carruthers, ... Journal of allergy and clinical immunology 134 (3), 679-687, 2014 | 394 | 2014 |
| Siglecs and immune regulation S Pillai, IA Netravali, A Cariappa, H Mattoo Annual review of immunology 30, 357-392, 2012 | 387 | 2012 |
| Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease H Mattoo, VS Mahajan, T Maehara, V Deshpande, E Della-Torre, ... Journal of Allergy and Clinical Immunology 138 (3), 825-838, 2016 | 368 | 2016 |
| Prevalence of atopy, eosinophilia, and IgE elevation in IgG4‐related disease H Mattoo, E Della Torre, VS Mahajan, M Carruthers, S Pillai, JH Stone Allergy, 2013 | 277* | 2013 |
| Predictors of disease relapse in IgG4-related disease following rituximab ZS Wallace, H Mattoo, VS Mahajan, M Kulikova, L Lu, V Deshpande, ... Rheumatology 55 (6), 1000-1008, 2016 | 198 | 2016 |
| Lesional CD4+ IFN-γ+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis T Maehara, H Mattoo, M Ohta, VS Mahajan, M Moriyama, M Yamauchi, ... Annals of the Rheumatic Diseases 76 (2), 377-385, 2017 | 190 | 2017 |
| T cell ageing: effects of age on development, survival & function N Salam, S Rane, R Das, M Faulkner, R Gund, U Kandpal, V Lewis, ... Indian Journal of Medical Research 138 (5), 595-608, 2013 | 167 | 2013 |
| Identification of galectin-3 as an autoantigen in patients with IgG4-related disease CA Perugino, SB AlSalem, H Mattoo, E Della-Torre, V Mahajan, ... Journal of Allergy and Clinical Immunology 143 (2), 736-745. e6, 2019 | 161 | 2019 |
| B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease E Della-Torre, E Feeney, V Deshpande, H Mattoo, V Mahajan, M Kulikova, ... Annals of the Rheumatic Diseases 74 (12), 2236-2243, 2015 | 141 | 2015 |
| Circulating T h2 memory cells in I g G 4‐related disease are restricted to a defined subset of subjects with atopy H Mattoo, E Della‐Torre, VS Mahajan, JH Stone, S Pillai Allergy 69 (3), 399-402, 2014 | 138 | 2014 |
| Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis T Maehara, N Kaneko, CA Perugino, H Mattoo, J Kers, H Allard-Chamard, ... The Journal of clinical investigation 130 (5), 2451-2464, 2020 | 130 | 2020 |
| B cells and autoimmunity S Pillai, H Mattoo, A Cariappa Current opinion in immunology 23 (6), 721-731, 2011 | 124 | 2011 |
| B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease E Della-Torre, E Rigamonti, C Perugino, S Baghai-Sain, N Sun, N Kaneko, ... Journal of Allergy and Clinical Immunology 145 (3), 968-981. e14, 2020 | 102 | 2020 |
| Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease H Mattoo, JH Stone, S Pillai Autoimmunity 50 (1), 19-24, 2017 | 99 | 2017 |
| Hypoxia drives transient site-specific copy gain and drug-resistant gene expression JC Black, E Atabakhsh, J Kim, KM Biette, C Van Rechem, B Ladd, ... Genes & development 29 (10), 1018-1031, 2015 | 99 | 2015 |
| A CD 8α− Subset of CD 4+ SLAMF 7+ Cytotoxic T Cells Is Expanded in Patients With IgG4‐Related Disease and Decreases Following Glucocorticoid Treatment E Della‐Torre, E Bozzalla‐Cassione, C Sciorati, E Ruggiero, M Lanzillotta, ... Arthritis & Rheumatology 70 (7), 1133-1143, 2018 | 94 | 2018 |
| Striking immune phenotypes in gene-targeted mice are driven by a copy-number variant originating from a commercially available C57BL/6 strain VS Mahajan, E Demissie, H Mattoo, V Viswanadham, A Varki, R Morris, ... Cell reports 15 (9), 1901-1909, 2016 | 80 | 2016 |
Shiv S PillaiProfessor of Medicine, Harvard Medical SchoolBestätigte E-Mail-Adresse bei helix.mgh.harvard.edu
